Mindray stock at CNY 161.40, 34.7 percent below its 52-week high
Published on 10/09/2026 at 16:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Mindray stock was last at CNY 161.40 on October 9, 2026, up 2.4 percent from the prior close.
- The price stood 34.7 percent below its CNY 247.00 52-week high.
- Market capitalization was CNY 195.7 billion, with a trailing P/E ratio of 24.9.
- The 2026 second-quarter revenue reached CNY 9.40 billion, while net profit was CNY 2.47 billion.
Mindray stock was last at CNY 161.40 on October 9, 2026, at 3:04 p.m. CST, up 2.4 percent from the prior close of CNY 157.60. The price stood 34.7 percent below its CNY 247.00 52-week high, placing the medical-device maker in the lower portion of its annual trading band.
Price remains below yearly high
The current quotation gives Mindray a market capitalization of CNY 195.7 billion and a trailing P/E ratio of 24.9. Its CNY 130.66 to CNY 247.00 52-week range shows a wide valuation gap between the recent market price and the yearly peak.
Trading activity also provides a useful reference point. Mindray recorded 6,943,867 shares in volume on October 9, against an average volume of 9,506,073 shares, while its dividend yield stood at 0.03 percent.
Revenue growth stays positive
According to min.news on October 9, 2026, Mindray generated CNY 17.75 billion in revenue during the first half of 2026, up 6.00 percent year over year. Net profit attributable to the parent company reached CNY 4.80 billion in the same period.
The second quarter delivered CNY 9.40 billion in revenue, an increase of 10.45 percent from the year-earlier quarter, while net profit rose 1.10 percent to CNY 2.47 billion, according to min.news. On October 9, Mindray also released its 2026 semiannual report.
Comparison with peers
Mindray: plus 2.4 percent, P/E 24.9, market capitalization CNY 195.7 billion
Jiangsu Yuyue Medical Equipment & Supply (Shenzhen Stock Exchange, CNY): plus 0.7 percent, P/E 23.2, market capitalization CNY 26.2 billion
Lepu Medical Technology (Beijing) (Shenzhen Stock Exchange, CNY): plus 1.9 percent, P/E 27.9, market capitalization CNY 21.5 billion
Target remains above market price
Yahoo Finance lists a one-year average analyst target of CNY 229.51 against a CNY 157.60 reference price at the October 8, 2026 close. That target is 45.65 percent above the reference price, while the latest quotation is 29.67 percent below the target. The figures describe market expectations rather than a recommendation.
Mindray trading snapshot
Mindray was last at CNY 161.40 on the Shenzhen Stock Exchange on October 9, 2026, at 3:04 p.m. CST, compared with CNY 157.60 at the prior close. The stock's 24.9 trailing P/E and CNY 195.7 billion market capitalization place valuation alongside the 2026 revenue growth figures.
Mindray stock facts
- Company: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- ISIN: CNE100003G67
- Ticker: 300760
- Primary exchange: Shenzhen Stock Exchange
- Price Shenzhen Stock Exchange (as of October 9, 2026, 3:04 p.m. CST): CNY 161.40
- Change versus prior close: plus 2.4 percent
- Prior close (October 8, 2026): CNY 157.60
- Market capitalization: CNY 195.7 billion (as of October 9, 2026)
- 52-week range: CNY 130.66-CNY 247.00 (as of October 9, 2026)
- Sector / Industry: Healthcare / Medical Devices
Market context: Market report Shanghai Composite.
